245 related articles for article (PubMed ID: 37279835)
1. A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f
Jeong YS; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):95-117. PubMed ID: 37279835
[TBL] [Abstract][Full Text] [Related]
2. Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.
Li X; Jusko WJ
Drug Metab Dispos; 2023 Oct; 51(10):1403-1418. PubMed ID: 37460222
[TBL] [Abstract][Full Text] [Related]
3. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
[TBL] [Abstract][Full Text] [Related]
4. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
Berezhkovskiy LM
J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
[TBL] [Abstract][Full Text] [Related]
5. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
6. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
Poulin P; Bteich M; Haddad S
J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
8. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
Wang HJ; Benet LZ
Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Kochak-Benet Equation for Hepatic Clearance for the Parallel-Tube Model: Relevance of Classic Clearance Concepts in PK and PBPK.
Jusko WJ; Li X
AAPS J; 2021 Dec; 24(1):5. PubMed ID: 34853928
[TBL] [Abstract][Full Text] [Related]
10. The Extended Clearance Concept Following Oral and Intravenous Dosing: Theory and Critical Analyses.
Benet LZ; Bowman CM; Liu S; Sodhi JK
Pharm Res; 2018 Oct; 35(12):242. PubMed ID: 30349948
[TBL] [Abstract][Full Text] [Related]
11. An integrated approach to model hepatic drug clearance.
Liu L; Pang KS
Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
[TBL] [Abstract][Full Text] [Related]
12. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept.
Sugiyama Y; Aoki Y
Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092
[TBL] [Abstract][Full Text] [Related]
13. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
Kosugi Y; Hosea N
Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
[TBL] [Abstract][Full Text] [Related]
14. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
Dong J; Park MS
Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation.
Liang X; Park Y; DeForest N; Hao J; Zhao X; Niu C; Wang K; Smith B; Lai Y
Drug Metab Dispos; 2020 Dec; 48(12):1283-1292. PubMed ID: 33037043
[TBL] [Abstract][Full Text] [Related]
16. Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model.
Hsu SH; Cheng AC; Chang TY; Pao LH; Hsiong CH; Wang HJ
Biomed Pharmacother; 2021 Sep; 141():111855. PubMed ID: 34229248
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Pharmacokinetic Mysteries of the Liver: Application of Series Compartment Models of Hepatic Elimination.
Li X; Jusko WJ
Drug Metab Dispos; 2023 May; 51(5):618-628. PubMed ID: 36732075
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance.
Liang X; Lai Y
Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):869-886. PubMed ID: 33793347
[No Abstract] [Full Text] [Related]
19. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.
Riley RJ; McGinnity DF; Austin RP
Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954
[TBL] [Abstract][Full Text] [Related]
20.
Li X; Jusko WJ
Drug Metab Dispos; 2022 Oct; ():. PubMed ID: 36195337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
